All News

Three-time cancer survivor tells about her experience with second opinions.

Jean M. Weigert, head of breast imaging for the Hospital of Central Connecticut, discusses results of a study examining supplemental ultrasound screening in women with dense breast tissue.

Melissa Long knows first-hand what it is like to battle isolation and depression as a teenage cancer survivor.

Oncologist Don Dizon explains the advantages of intraperitoneal therapy and why further research and education are necessary to bring it to the forefront of ovarian cancer treatment.

Elizabeth A. Mittendorf, associate professor of surgical oncology at The University of Texas MD Anderson Cancer Center, discusses the progress and potential of immunotherapy in breast cancer treatment.

The development of agents targeting the PD-1 immune checkpoint in the treatment of patients with advanced melanoma is progressing rapidly.

A trial comparing frontline Keytruda (pembrolizumab) with Yervoy (ipilimumab) for the treatment of advanced melanoma has met its progression-free survival and overall survival endpoints.

Anger is a common emotional response to being diagnosed with and treated for cancer. Openly expressing it can be a struggle.

Two years ago, Angelina Jolie Pitt told the world that she held the BRCA1 mutation.

Recent advancements in the treatment of ovarian cancer, including surgical techniques, the approvals of Avastin and Lynparza, and intraperitoneal chemotherapy, have led the National Comprehensive Cancer Network to make changes to their clinical practice guidelines in its 20th annual edition.

Results of a follow up study have shown that when women were taught stress management techniques early in their breast cancer treatment, their mood and quality of life continued to improve up to 15 years later.

Breast cancer specialist Mark Pegram discusses recent breast cancer studies and what's to come for patients with HER2-positive breast cancer.

In the ring, it's not about whether you win or lose; it's about never staying down and never giving up.

Two studies investigating Xtandi in men with early-stage metastatic castration-resistant prostate cancer (mCRPC) further confirmed the overall survival (OS) and progression-free survival (PFS) benefit of the agent over placebo, according to two recent studies.

Surgical oncologist Kelly K. Hunt, of MD Anderson Cancer Center, discusses how breast cancer interventions have progressed in the adjuvant and neoadjuvant setting and the role of sentinel lymph node dissection in the neoadjuvant setting.

PCF's Challenge Awards advance immunotherapy and optimal treatments for lethal prostate cancer.

Leaving the hospital is a huge relief, but there's still lots of work to do.

When my doctor told me that I had stage 4, grade 3a follicular lymphoma, I thought that it was impossible: I had firmly put cancer in my rear view mirror seven years prior. Yet here I was, hearing for the word "cancer" for the second time by the age of 26.

First-line treatment with Tykerb and a taxane failed to improve progression-free survival versus Herceptin plus a taxane in patients with HER2-positive metastatic breast cancer.

Saying goodbye to a friend in the middle of a shared cancer diagnosis can challenge the soul.

The PCF announced six new Challenge Awards to advance the treatment of lethal prostate cancer.

Another trip around the sun is quite a reason to celebrate when living with metastatic lung cancer.

March is Colorectal Cancer Awareness month and I'm happy to be part of the sea of blue that is preventing others from enduring a diagnosis of colon cancer.

Following cancer treatment, I wanted to regain some strength and stamina. Where would I start?

Genetic testing is a fascinating and provocative aspect of medicine today as it has implications for our some of our most pronounced human experiences: life, death, reproduction, parenthood, familial bonds, and one's mortality.

Inflammatory breast cancer survivor, Terry Arnold, shares her story of diagnosis and survivorship.

As a side effect of breast cancer treatment, many women develop lymphedema in the arm and upper body.

When I was diagnosed with breast cancer in 1986, no one talked about fear of recurrence and how devastating it can be in our lives.